NCT01622933 2017-08-31Multiple Antigen-Engineered DC Vaccine for MelanomaUniversity of PittsburghPhase 1 Completed35 enrolled
NCT00329368 2012-03-09Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic CancerEndocytePhase 1 Completed13 enrolled